PRESS

The talk on the town.

Our AI-driven voice analysis is making a real impact on mental healthcare.
Read what the press has to say about Kintsugi.
December 7, 2022
Galen Growth

HealthTech 250: The Most Promising Early-stage Digital Health Ventures in 2022

Kintsugi has been named to Galen Growth | Global HealthTech Insights HealthTech 250: The Most Promising Early-stage Digital Health Ventures in 2022.
Read Full Article
November 21, 2022
Psychology Today

AI can use your voice to detect depression

Kintsugi was featured in Psychology Today as an AI voice biomarker tool that has the potential to more objectively identify signs of depression than existing mental health screening methods.
Read Full Article
October 21, 2022
Axios

"Voice biomarker" tech analyzes your voice for signs of depression

Kintsugi CEO & Founder, Grace Chang, was featured in Axios, for framing up what voice biomarker technology is and how it can be used to aid clinicians in the identification of medical issues.
Read Full Article
September 20, 2022
Frost & Sullivan

Frost & Sullivan: Innovation Leader in Voice Biomarkers for Mental Health

Frost & Sullivan presents Kintsugi with Best Practices Technology Innovation Leadership Award in North America for vocal biomarkers in the mental health industry.
Read Full Article
September 13, 2022
Gartner

2022 Gartner Cool Vendor in AI Governance and Responsible AI

Kintsugi is recognized by Gartner as being at the forefront of innovation and growth, and for being the first and only voice biomarker technology that is developing a real-time mental health assessment that aims to bridge important access gaps in mental healthcare.
Read Full Article